시장보고서
상품코드
1429446

세계의 제네릭 의약품 시장 보고서(2024년)

Generic Pharmaceuticals Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

제네릭 의약품 시장 규모는 향후 몇 년 동안 크게 성장할 것으로 예상됩니다. 2028년에는 연평균 6.3%의 복합 성장률(CAGR)로 5,148억 1,000만 달러 규모로 성장할 것으로 예상됩니다. 이러한 성장은 만성질환 발생률 증가, 규제 지원 증가, 신약 개발 및 전달 방법의 발전, 의료비 증가, 노인 인구 증가, 주요 의약품 특허에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 3D 프린팅 사용 증가, 인공지능(AI) 도입, 의약품 개발에서 바이오마커 활용, 혁신 추진을 위한 협업, 병용요법, 기존 간질약의 개선, 호흡기 제네릭 의약품의 부상 등이 있습니다.

만성질환의 유병률 증가는 제네릭 의약품 시장의 중요한 촉진요인으로 부각되고 있습니다. 만성질환 진단을 받는 인구가 증가함에 따라 의약품에 대한 수요가 증가하고 있습니다. 브랜드 의약품은 종종 고가이지만, 제네릭 의약품은 동일한 화학 성분을 저렴한 가격으로 제공합니다. 제네릭 의약품은 저렴한 가격과 동등한 효과로 인해, 특히 만성 질환에 따른 장기 치료의 경우 환자들에게 선호되는 선택이 되고 있습니다. 예를 들어, 세계보건기구(WHO)는 향후 10년간 만성질환으로 인한 사망률이 17% 증가할 것으로 예상하고 있습니다.

제네릭 의약품을 통한 비용 효율적인 치료에 대한 기대가 제네릭 의약품 시장의 성장을 촉진할 것으로 예상됩니다. 비용 효율적인 치료는 합리적인 비용으로 높은 수준의 건강상의 이점을 달성해야 합니다. 제네릭 의약품은 저렴한 가격으로 유명하며, 브랜드 의약품에 비해 환자에게 상당한 비용 절감 효과를 제공할 뿐만 아니라 전체 의료 시스템 비용 절감에도 기여합니다. 일례로, Accessible Pharmaceuticals Association이 제공한 2021년 데이터에 따르면 제네릭 처방전의 평균 본인 부담금은 6.61달러로 브랜드 의약품의 평균 본인 부담금 55.82달러보다 훨씬 낮은 것으로 나타났습니다. 따라서 제네릭 의약품을 통한 비용 효율적인 치료 추구는 제네릭 의약품 시장 성장의 중요한 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 제네릭 의약품 시장, 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 바이오시밀러
  • 제네릭
  • 세계의 제네릭 의약품 시장, 약물전달별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 경구
  • 주사
  • 피부/외용
  • 세계의 제네릭 의약품 시장, 치료별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • CNS
  • 심혈관
  • 피부과
  • 비뇨생식기/호르몬
  • 호흡기계
  • 류머티즘과
  • 당뇨병
  • 종양학
  • 흡입기
  • 세계의 제네릭 의약품 시장, 유통 채널별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제7장 지역 및 국가 분석

  • 세계의 제네릭 의약품 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 제네릭 의약품 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 제네릭 의약품 시장 경쟁 상황
  • 제네릭 의약품 시장 기업 개요
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • Sun Pharmaceutical Industries Ltd.
    • Fresenius Kabi
    • Aurobindo Pharma Limited

제31장 기타 주요 및 혁신적인 기업

  • Cipla Limited
  • Stada Arzneimittel AG
  • Lupin Pharmaceuticals, Inc.
  • Dr. Reddy's Laboratories
  • Mylan Inc.
  • Shanghai Generic Pharmaceuticals
  • Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd.
  • Sandoz
  • Glenmark
  • Kent Pharma
  • GlaxoSmithKline(GSK)
  • Zentiva
  • Sanofi
  • Merck &Co.
  • Apotex

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

Generic pharmaceuticals are drugs designed to replicate an already marketed brand-name drug in terms of dosage form, safety, strength, mode of administration, quality, performance attributes, and intended use. The clinical benefits and action of a generic drug are identical to those of its brand-name counterpart.

The three primary types of generic pharmaceuticals are biosimilars and generics. Biosimilars are biological products closely resembling a reference biologic, demonstrating no clinically significant differences in safety, purity, or potency. These drugs are administered through various methods, including oral, injectable, dermal/topical, and inhalers, catering to therapies such as CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, biosimilars, and oncology. Distribution channels encompass hospital pharmacies, retail pharmacies, and online pharmacies.

The generic pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides generic pharmaceuticals market statistics, including generic pharmaceuticals industry global market size, regional shares, competitors with a generic pharmaceuticals market share, detailed generic pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the generic pharmaceuticals industry. The generic pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The generic pharmaceuticals market size has grown strongly in recent years. It will grow from $381 billion in 2023 to $402.97 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The historical growth can be attributed to an increase in healthcare awareness and expenditure, patent expiration of drugs, a higher prevalence of respiratory diseases, lifestyle changes, a rise in the number of surgical procedures, robust economic growth in emerging markets, expanded insurance coverage, rapid growth in the elderly population, and an increased number of approvals.

The generic pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $514.81 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The forecasted growth can be attributed to the increasing incidence of chronic diseases, growing regulatory support, advancements in drug discovery and delivery methods, increased healthcare expenditure, a rising geriatric population, and significant drug patents. Major trends in the forecast period include the increasing use of 3D printing, adoption of artificial intelligence (AI), utilization of biomarkers for drug development, collaborations to drive innovation, combination drug therapy, modification of existing epilepsy drugs, and the rise of generic respiratory drugs.

The increasing prevalence of chronic diseases stands out as a significant driver for the generic pharmaceuticals market. As the number of individuals diagnosed with chronic conditions rises, there is a growing demand for medications. Branded drugs often come with a premium price tag, whereas generic drugs offer the same chemical composition at a lower cost. The affordability and comparable effectiveness of generic drugs make them a preferred choice for patients, particularly for prolonged treatments associated with chronic diseases. For instance, the World Health Organization (WHO) projects a 17% increase in deaths due to chronic diseases over the next decade.

The anticipation of cost-effective treatment through generic drugs is expected to fuel the growth of the generic pharmaceutical market. Cost-effective treatment entails achieving a high level of health benefits at a reasonable cost. Generic drugs, known for their affordability, not only offer substantial cost savings for patients but also contribute to overall healthcare system savings compared to their branded counterparts. As an example, data from 2021, provided by the Association for Accessible Medicines, reveals that the average out-of-pocket cost for a generic prescription is $6.61, significantly lower than the average out-of-pocket cost of $55.82 for a brand-name drug. Consequently, the pursuit of cost-effective treatment with generic drugs is a key driver behind the growth of the generic pharmaceutical market.

The advent of 3D printing technology holds the potential to revolutionize drug manufacturing within the generic pharmaceuticals market. The utilization of 3D printing in pharmaceuticals enhances research and development (R&D) efficiency, offering novel advantages for patients. Unlikeas traditional methods of generic drug manufacturing, 3D printing enables the production of drugs with customized sizes, shapes, and textures. This technology empowers manufacturers to create generic drugs with diverse release dates, appearances, and tastes. For example, GlaxoSmithKline (GSK) conducted a study incorporating ultraviolet (UV) and 3D printing to manufacture tablets for treating Parkinson's disease. Martin Wallace, the director of GSK Technology, expressed the company's commitment to investing in 3D printing for pill and tablet production. Additionally, Aprecia, a pharmaceutical company, introduced 'ZipDose' technology, specializing in the manufacture of 3D-printed drugs.

Leading companies in the generic pharmaceuticals market are actively introducing new products to maximize their market share and profits. The introduction of generic pharmaceutical products involves launching a generic version of a brand-name drug. For instance, in July 2023, Amneal Pharmaceuticals Inc., a publicly traded generics and specialty pharmaceutical company based in the United States, released its authorized generic for Xyrem 1 (Sodium Oxybate) oral solution CIII in the U.S. Sodium oxybate oral solution, 0.5 g/mL, is a central nervous system depressant prescribed for narcoleptic patients aged seven and older experiencing cataplexy or excessive daytime sleepiness (EDS).

In April 2021, Hikma Pharmaceuticals PLC, a UK-based manufacturer of non-branded generic and in-licensed pharmaceutical products, acquired Custopharm Inc. for $425 million. This strategic acquisition enhances Hikma's distinctive U.S. portfolio, with nearly 130 commercialized injectable medications-a more than fivefold increase over the past decade-and strengthens the company's research and development capabilities and pipeline. Custopharm Inc. is a U.S.-based developer of generic pharmaceuticals.

Major companies operating in the generic pharmaceuticals market report are Teva Pharmaceutical Industries Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Fresenius Kabi, Aurobindo Pharma Limited, Cipla Limited, Stada Arzneimittel AG, Lupin Pharmaceuticals, Inc., Dr. Reddy's Laboratories, Mylan Inc., Shanghai Generic Pharmaceuticals, Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd., Sandoz, Glenmark, Kent Pharma, GlaxoSmithKline (GSK), Zentiva, Sanofi, Merck & Co., Apotex, Pfizer, Gilead Sciences, Roche, Bayer, AbbVie Inc., AstraZeneca, Amgen, Abbott Laboratories, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Pharmaceutical Drugs Corporation, AA Pharma Inc., Sanfer, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, Johnson and Johnson, Bristol Myers Squibb, Eli Lilly & Company, Biogen, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Uniao Quimica, Boehringer Ingelheim, Mantecorp Farmasa, Libbs, Cimed, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Adcock Ingram, Eurolab, Ranbaxy (Pty) Ltd., Aspen

North America was the largest region in the generic pharmaceuticals market in 2023. Middle East is expected to be the fastest-growing region in the generic pharmaceuticals market report during the forecast period. The regions covered in the generic pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the generic pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The generic pharmaceuticals market consists of sales of paracetamol, cefixime, amoxicillin, and ofloxacin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generic Pharmaceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generic pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generic pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generic pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Biosimilars; Generics
  • 2) By Drug Delivery: Oral; Injectables; Dermal/Topical; Inhaled
  • 3) By Therapy: CNS; Cardiovascular; Dermatology; Genitourinary/Hormonal; Respiratory; Rheumatology; Diabetes; Oncology; Biosimilars; Others
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; And Online Pharmacies
  • Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Novartis AG; Sun Pharmaceutical Industries Ltd.; Fresenius Kabi; Aurobindo Pharma Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Generic Pharmaceuticals Market Characteristics

3. Generic Pharmaceuticals Market Trends And Strategies

4. Generic Pharmaceuticals Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Generic Pharmaceuticals Market Size and Growth

  • 5.1. Global Generic Pharmaceuticals Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Generic Pharmaceuticals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Generic Pharmaceuticals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Generic Pharmaceuticals Market Segmentation

  • 6.1. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biosimilar
  • Generics
  • 6.2. Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Injectables
  • Dermal/Topical
  • 6.3. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • CNS
  • Cardiovascular
  • Dermatology
  • Genitourinary/Hormonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Inhaler
  • 6.4. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

7. Generic Pharmaceuticals Market Regional And Country Analysis

  • 7.1. Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Generic Pharmaceuticals Market

  • 8.1. Asia-Pacific Generic Pharmaceuticals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Generic Pharmaceuticals Market

  • 9.1. China Generic Pharmaceuticals Market Overview
  • 9.2. China Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Generic Pharmaceuticals Market

  • 10.1. India Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Generic Pharmaceuticals Market

  • 11.1. Japan Generic Pharmaceuticals Market Overview
  • 11.2. Japan Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Generic Pharmaceuticals Market

  • 12.1. Australia Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Generic Pharmaceuticals Market

  • 13.1. Indonesia Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Generic Pharmaceuticals Market

  • 14.1. South Korea Generic Pharmaceuticals Market Overview
  • 14.2. South Korea Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Generic Pharmaceuticals Market

  • 15.1. Western Europe Generic Pharmaceuticals Market Overview
  • 15.2. Western Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Generic Pharmaceuticals Market

  • 16.1. UK Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Generic Pharmaceuticals Market

  • 17.1. Germany Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Generic Pharmaceuticals Market

  • 18.1. France Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Generic Pharmaceuticals Market

  • 19.1. Italy Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Generic Pharmaceuticals Market

  • 20.1. Spain Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Generic Pharmaceuticals Market

  • 21.1. Eastern Europe Generic Pharmaceuticals Market Overview
  • 21.2. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Generic Pharmaceuticals Market

  • 22.1. Russia Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Generic Pharmaceuticals Market

  • 23.1. North America Generic Pharmaceuticals Market Overview
  • 23.2. North America Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Generic Pharmaceuticals Market

  • 24.1. USA Generic Pharmaceuticals Market Overview
  • 24.2. USA Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Generic Pharmaceuticals Market

  • 25.1. Canada Generic Pharmaceuticals Market Overview
  • 25.2. Canada Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Generic Pharmaceuticals Market

  • 26.1. South America Generic Pharmaceuticals Market Overview
  • 26.2. South America Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Generic Pharmaceuticals Market

  • 27.1. Brazil Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Generic Pharmaceuticals Market

  • 28.1. Middle East Generic Pharmaceuticals Market Overview
  • 28.2. Middle East Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Generic Pharmaceuticals Market

  • 29.1. Africa Generic Pharmaceuticals Market Overview
  • 29.2. Africa Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Generic Pharmaceuticals Market Competitive Landscape And Company Profiles

  • 30.1. Generic Pharmaceuticals Market Competitive Landscape
  • 30.2. Generic Pharmaceuticals Market Company Profiles
    • 30.2.1. Teva Pharmaceutical Industries Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sun Pharmaceutical Industries Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Fresenius Kabi
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Aurobindo Pharma Limited
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Generic Pharmaceuticals Market Other Major And Innovative Companies

  • 31.1. Cipla Limited
  • 31.2. Stada Arzneimittel AG
  • 31.3. Lupin Pharmaceuticals, Inc.
  • 31.4. Dr. Reddy's Laboratories
  • 31.5. Mylan Inc.
  • 31.6. Shanghai Generic Pharmaceuticals
  • 31.7. Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd.
  • 31.8. Sandoz
  • 31.9. Glenmark
  • 31.10. Kent Pharma
  • 31.11. GlaxoSmithKline (GSK)
  • 31.12. Zentiva
  • 31.13. Sanofi
  • 31.14. Merck & Co.
  • 31.15. Apotex

32. Global Generic Pharmaceuticals Market Competitive Benchmarking

33. Global Generic Pharmaceuticals Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market

35. Generic Pharmaceuticals Market Future Outlook and Potential Analysis

  • 35.1 Generic Pharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Generic Pharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Generic Pharmaceuticals Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제